Skip to main content
SpringerLink
Log in

Interactions of three inotropic agents, ASL-7022, dobutamine and dopamine, with α- and β-adrenoceptors in vitro

  • Published:
Naunyn-Schmiedeberg's Archives of Pharmacology Aims and scope Submit manuscript

Summary

Three inotropic agents, ASL-7022, dobutamine and dopamine, were evaluated for their α-and β-adrenoceptor mediated effects in vitro in a variety of isolated organs and in radioligand binding studies. All compounds were α1-adrenoreceptor agonists in rat and guinea pig aortae, but the rank orders of potency were exactly opposite in these two tissues. Only the rank potency order of dobutamine>ASL-7022>dopamine obtained in rat aorta was consistent with the results obtained in radioligand binding studies to α1-adrenoreceptors in rat cerebral cortex and to previous results obtained in vivo in the pithed rat. The results obtained in guinea pig aorta did not parallel the radioligand binding studies in rat brain or our previous results in pithed rat, and suggests that species differences exist between postsynaptic vascular α1-adrenoreceptors in rat and guinea pig aorta, consistent with previous conclusions. ASL-7022 was found to be a potent α2-adrenoreceptor agonist in field-stimulated guinea pig ileum, and was approximately 10-fold more potent than dobutamine in this respects, which was also confirmed by radioligand binding studies to α2-adrenoreceptors in rat cerebral cortex. The β1-adrenoreceptor mediated effects of these compounds were evaluated in guinea pig atria, where the rank order of potency was dobutamine>ASL-7022>dopamine. An identical rank order of affinity was established for these compounds by displacement of 3H-dihydroalprenolol from β1-adrenoreceptors in rat cerebral cortex. The β1-adrenoreceptor mediated effects of dobutamine and ASL-7022 in guinea pig atria were completely direct in nature and not secondary to the release of endogenous catecholamines. In contrast, a major component of the β1-adrenoreceptor mediated tachycardia produced by dopamine in guinea pig atria was indirect in nature as evidenced by the marked attenuation in potency that occurred following catecholamine depletion with reserpine. All three compounds elicited β2-adrenoreceptor mediated inhibition of tone in rat uterus, with the rank order of potency being ASL-7022>dobutamine>dopamine. Again, this rank order of β2-adrenoreceptor potency was also reflected in β2-adrenoreceptor affinity as assessed by displacement of 3H-dihydroalprenolol from β2-adrenoreceptors in rat cerebellum. Based on these results, it may be concluded that for α-adrenoceptors, dobutamine is a selective β2-adrenoreceptor agonist, ASL-7022 is a selective α2-adrenoreceptor agonist, and dopamine is a nonselective α-adrenoceptor agonist. For β-adrenoceptor mediated effect, ASL-7022 is a selective α2 agonist, while dobutamine and dopamine are nonselective β-adrenoceptor agonists. It is likely that the complex inotropic and hemodynamic activities of ASL-7022, dobutamine and dopamine result from the sum of their individual effects at the α-and β-adrenoceptor subtypes.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  • Allwood MJ, Cobbold AF, Ginsburg J (1963) Peripheral vascular effects of noradrenaline, isopropylnoradrenaline and dopamine. Br Med Bull 19:132–136

    Google Scholar 

  • Beckeringh JJ, Thoolen MJMC, de Jonge A, Wilffert B, Timmermans PBMWM, van Zwieten PA (1984) Differential effects of the calcium entry blocker, D 600, on contractions of rat and guinea pig aortas elicited by various α1-adrenoreceptor agonist. J Pharmacol Exp Ther (in press)

  • Bilski AJ, Halliday SE, Fitzgerald JD, Wale JL (1983) The pharmacology of a β2-selective adrenoceptor antagonist (ICI 118551). J Cardiovasc Pharmacol 5:430–437

    Google Scholar 

  • Broadley KJ (1982) Cardiac adrenoreceptors. J Auton Pharmacol 2:119–145

    Google Scholar 

  • Carlsson E, Ablad B, Brandstrom A, Carlsson B (1972) Differentiated blockade of the chronotropic effects of various adrenergic stimuli in the cat heart. Life Sci 11:953–958

    Google Scholar 

  • Chiba S, Watanabe H, Kobayashi M, Iwatsuki K (1983) Cardiovascular effects of dobutamine, dopamine and isoproterenol on the whole animal and isolated cross-perfused atrium in dogs. Jpn J Pharmacol 33:113–119

    Google Scholar 

  • Covell JW, Chidsey CA, Braunwald E (1966) Reduction in cardiac response to postganglionic sympathetic nerve stimulation in experimental heart failure. Circ Res 19:51–56

    Google Scholar 

  • Doxey JC, Roach AG (1980) Presynaptic α-adrenoreceptors; in vitro methods and preparations utilized in the evaluation of agonists and antagonists. J Auton Pharmacol 1:73–99

    Google Scholar 

  • Drew GM (1978) Pharmacological characterization of the presynaptic α-adrenoceptors regulating cholinergic activity in the guinea pig ileum. Br J Pharmacol 64:293–300

    Google Scholar 

  • Drew GM (1980) Postsynaptic α-adrenoreceptors mediate pressor responses to 2-N,N-dimethylamino-5,6-dihydroxy-1,2,3,4-tetrahydronaphthalene (M-7). Eur J Pharmacol 65:85–87

    Google Scholar 

  • Endoh M (1983) Inhibition of the positive inotropic effect of dopamine by YM-09538 with α-and β-adrenoceptor antagonistic action in the rabbit papillary muscle. Jpn J Pharmacol 33:897–899

    Google Scholar 

  • Endoh M, Schümann HJ, Krappitz N, Hillen B (1976) α-Adrenoceptors mediating positive inotropic effects on the ventricular myocardium: some aspects of structure-activity relationships of sympathomimetic amines. Jpn J Pharmacol 26:179–190

    Google Scholar 

  • Farmer JB (1966) Indirect sympathomimetic actions of dopamine. J Pharm Pharmacol 18:261–262

    Google Scholar 

  • Furchgott RF, Bhadrakom S (1953) Reactions of strips of rabbit aorta to epinephrine, isoproterenol, sodium nitrite and other drugs. J Pharmacol Exp Ther 142:39–58

    Google Scholar 

  • Goldberg LI (1972) Cardiovascular and renal actions of dopamine: potential clinical applications. Pharmacol Rev 24:1–29

    Google Scholar 

  • Gorczynski RJ (1982) Cardiovascular pharmacology of ASL-7022, a novel catecholamine. I. Inotropic, chronotropic and pressor actions. J Pharmacol Exp Ther 223:7–11

    Google Scholar 

  • Gorczynski RJ, Wroble RW (1982) Cardiovascular pharmacology of ASL-7022. II. Mechanisms of inotropic selectivity. J Pharmacol Exp Ther 223:12–19

    Google Scholar 

  • Guimaraes S (1969) Reversal by pronethalol of dibenamine blockade: a study on the seminal vesicle of the guinea pig. Br J Pharmacol 36:594–601

    Google Scholar 

  • Hicks PE, Cannon JC (1979) N,N-dialkyl derivatives of 2-amino-5,6-dihydroxy-1,2,3,4-tetrahydronaphthalene as selective agonists at presynaptic α-adrenoceptors in the rat. J Pharm Pharmacol 31:494–496

    Google Scholar 

  • Iversen LL (1966) The uptake and storage of noradrenaline in sympathetic nerves. Cambridge University Press, Cambridge

    Google Scholar 

  • Kaumann AJ (1981) In kitten ventricular myocardium, the inotropic potency of an agonist is determined by both its intrinsic activity for the adenylyl cyclase and its affinity for the β-adrenoceptors. Naunyn-Schmiedeberg's Arch Pharmacol 317:13–18

    Google Scholar 

  • Kenakin TP (1981) An in vitro quantitative analysis of the α-adrenoreceptor partial agonist activity of dobutamine and its relevance to inotropic selectivity. J Pharmacol Exp Ther 216:210–219

    Google Scholar 

  • Kenakin TP (1983) Receptor classification by selective agonists: coping with circularity and circumstantial evidence. Trends Pharmacol Sci 4:291–295

    Google Scholar 

  • Langer SZ, Massingham R, Shepperson N (1980) Presence of post-synaptic α2-adrenoreceptors of predominantly extrasynaptic location in the vascular smooth muscle of the dog hind limb. Clin Sci 59:225s-228s

    Google Scholar 

  • Leier CV, Unverferth DV (1983) Dobutamine. Ann Intern Med 99:490–496

    Google Scholar 

  • Leier CV, Heban PT, Huss P, Bush CA, Lewis RP (1980) Comparative systemic and hemodynamic effects of dopamine and dobutamine in patients with cardiomyopathic heart failure. In: Bleifeld W, Gattikere R, Schaper W, Brade W (eds) Internationales dobutamine symposium. Urban and Schwarzenberg, Munich, pp 177–183

    Google Scholar 

  • Liang C-S, Hood WB (1979) Dobutamine infusion in conscious dogs with an without autonomic nervous system inhibition: Effects on systemic hemodynamics, regional blood flows and cardiac metabolism. J Pharmacol Exp Ther 211:698–705

    Google Scholar 

  • Lowry OH, Rosebrough NJ, Farr AL, Randall RJ (1951) Protein measurement with the Folin phenol reagent. J Biol Chem 193:265–275

    Google Scholar 

  • Manalan AS, Besch Jr HR, Watanabe AM (1981) Characterization of 3H(±)-carazolol binding to β-adrenergic receptors. Circ Res 49:325–336

    Google Scholar 

  • McGrath JC (1982) Evidence for more than one type of post-junctional α-adrenoceptor. Biochem Pharmacol 31:467–484

    Google Scholar 

  • Minneman KP, Hegstrand LR, Molinoff PB (1979) Simultaneous determination of β1 and β2-adrenergic receptors in tissues containing both receptor subtypes. Mol Pharmacol 16:34–46

    Google Scholar 

  • Nahorski SR (1978) Heterogeneity of cerebral β-adrenoceptor binding sites in various vertebrate species. Eur J Pharmacol 51:199–209

    Google Scholar 

  • Patil PN, Fudge K, Jacobowitz D (1972) Steric aspects of adrenergic drugs. XVIII. α-Adrenergic receptors of mammalian aorta. Eur J Pharmacol 19:70–87

    Google Scholar 

  • Patil PN, Miller DD, Trendelenburg U (1974) Molecular geometry and adrenergic drug activity. Pharmacol Rev 26:323–392

    Google Scholar 

  • Robie NW, Nutter DO, Moody C, McNay JL (1974) In vivo analysis of adrenergic receptor activity of dobutamine. Circ Res 34:663–671

    Google Scholar 

  • Rossum JM van (1963) Cumulative dose-response curves. II. Technique for the making of dose-response curves in isolated organs and the evaluation of drug parameters. Arch Int Pharmacodyn Ther 143:299–330

    Google Scholar 

  • Ruffolo RR Jr (1982) Important concepts of receptor theory. J Auton Pharmacol 2:277–295

    Google Scholar 

  • Ruffolo RR Jr (1983) Structure-activity relationships of α-adrenoceptor agonists. In: Kunos G (ed) Adrenoceptors and catecholamine action, part B. John Wiley and Sons Inc., New York, pp 1–50

    Google Scholar 

  • Ruffolo RR Jr (1984) Alpha-Adrenoceptors. In: Cohen MM (ed) Neuroreceptors in health and disease, monographs in neural sciences, vol 10. Karger, Basel, pp 224–253

    Google Scholar 

  • Ruffolo RR Jr, Shaar CJ (1983) Relative potency of LY 141865 at dopamine DA2 and histamine H2 receptors. Eur J Pharmacol 92:295–296

    Google Scholar 

  • Ruffolo RR Jr, Waddell JE (1982) Stereochemical requirements of α2-adrenergic receptors for α-methyl substituted phenethylamines. Life Sci 31:2999–3007

    Google Scholar 

  • Ruffolo RR Jr, Yaden EL (1983a) Vascular effects of the stereoisomers of dobutamine. J Pharmacol Exp Ther 224:46–50

    Google Scholar 

  • Ruffolo RR Jr, Yaden EL (1983b) Selective α2-adrenoreceptor agonist activity of the novel inotropic agent, ASL-7022: Comparison with dobutamine. Eur J Pharmacol 93:117–120

    Google Scholar 

  • Ruffolo RR Jr, Yaden EL (1984) Interaction of the novel inotropic agent, ASL-7022, with α-and β-adrenoceptors in the cardiovascular system of the pithed rat: comparison with dobutamine and dopamine. J Pharmacol Exp Ther (in press)

  • Ruffolo RR Jr, Spradlin TA, Pollock GD, Waddell JE, Murphy PJ (1981) α-and β-adrenergic effects of the stereoisomers of dobutamine. J Pharmacol Exp Ther 219:447–452

    Google Scholar 

  • Ruffolo RR Jr, Waddell JE, Yaden EL (1982a) Heterogeneity of postsynaptic α-adrenergic receptors in mammalian aortas. J Pharmacol Exp Ther 221:309–314

    Google Scholar 

  • Ruffolo RR Jr, Yaden EL, Waddell JE (1982b) Stereochemical requirements of α2-adrenergic receptors. J Pharmacol Exp Ther 222:645–651

    Google Scholar 

  • Schümann HJ (1980) Are there α-adrenoceptors in the mammalian heart. Trends Pharmacol Sci 2:195–197

    Google Scholar 

  • Schümann HJ, Brodde OE (1979) Demonstration of α-adrenoceptors in the rabbit heart by 3H-dihydroergocryptine binding. Naunyn-Schmiedeberg's Arch Pharmacol 308: 191–198

    Google Scholar 

  • Schümann HJ, Endoh M (1976) α-Adrenoceptors in the ventricular myocardium: clonidine, naphazoline and methoxamine as partial α agonists exerting a competitive dualism in action to phenylephrine. Eur J Pharmacol 36:413–421

    Google Scholar 

  • Schümann HJ, Endoh M, Wagner J (1974) Positive inotropic effects of phenylephrine in the isolated rabbit papillary muscle mediated both by α-and β-adrenoceptors. Naunyn-Schmiedeberg's Arch Pharmacol 284:133–148

    Google Scholar 

  • Schümann HJ, Endoh M, Brodde OE (1975) The time course of the effects of β-and α-adrenoceptor stimulation by isoprenaline and methoxamine on the contractile force and cAMP level of the isolated rabbit papillary muscle. Naunyn-Schmiedeberg's Arch Pharmacol 289:291–302

    Google Scholar 

  • Schümann HJ, Wagner J, Knorr A, Reidemeister JC, Sadony V, Schramm G (1978) Demonstration in human artrial preparations of α-adrenoreceptors mediating positive inotropic effects. Naunyn-Schmiedeberg's Arch Pharmacol 302: 333–336

    Google Scholar 

  • Sokal RA, Rohlf FJ (1969) Regression. In: Biometry. W. H. Freeman and Company, San Francisco, pp 404–493

    Google Scholar 

  • Sonnenblick EH, Frishman WH, Lejemtel TH (1979) Dobutamine: A new synthetic cardioactive sympathetic amine. N Engl J Med 300:17–22

    Google Scholar 

  • Starke K, Endo T, Taube HD (1975) Relative pre- and postsynaptic potencies of α-adrenoceptor agonists in the rabbit pulmonary artery. Naunyn-Schmiedeberg's Arch Pharmacol 291:55–78

    Google Scholar 

  • Stoner JD, Bolen JL, Harrison DL (1977) Comparison of dobutamine and dopamine in severe heart failure. Br Heart J 39:563

    Google Scholar 

  • The Staff of the Department of Pharmacology, University of Edinburgh (1968) Experiments with heart muscle. In: Perry WLM (ed) Pharmacological experiments on isolated preparations. E and S Livingstone Ltd, London, pp 104–111

    Google Scholar 

  • Timmermans PBMWM, Wilffert B, Davidesko D, Mathy MJ, Dijkstra D, Horn AS, Zwieten PA van (1983) Re-evaluation of the selectivity of 2-N,N-dimethylamino-5,6-dihydroxy-1,2,3,4-tetrahydronaphthalene (M-7) as an agonist of postjunctional α2-adrenoreceptors in the pithed normotensive rat. J Pharmacol Exp Ther 225:407–409

    Google Scholar 

  • Trendelenburg U (1972) Factors influencing the concentration of cetecholamines at the receptors. In: Blaschko H, Muscholl E (eds) Catecholamines handbook of experimental pharmacology, vol 33. Springer, Berlin Heidelberg New York, pp 726–761

    Google Scholar 

  • Triggle CR, Triggle DJ (1976) Structure and function of the synapse. In: Triggle DJ, Triggle CR (eds) Chemical pharmacology of the synapse. Academic Press, New York, pp 1–127

    Google Scholar 

  • Tuttle RR, Mills J (1975) Dobutamine: Development of a new catecholamine to selectively increase cardiac contractility. Circ Res 36:185–196

    Google Scholar 

  • U'Prichard DC, Snyder SH (1979) Distinct α-noradrenergic receptors differentiated by binding and physiologiclal relationships. Life Sci 24:79–88

    Google Scholar 

  • U'Prichard DC, Reisine TD, Yamamura S, Mason ST, Fibiger HC, Ehlert F, Yamamura HI (1980) Differential supersensitivity of β-receptor subtypes in rat cortex and cerebellum after central noradrenergic denervation. Life Sci 26:355–364

    Google Scholar 

  • Vatner SF, McRitchie RJ, Braunwald E (1974) Effects of dobutamine on left ventricular performance, coronary dynamics and distribution of cardiac output in conscious dogs. J Clin Invest 53:1265–1273

    Google Scholar 

  • Verity MA, Bevan JA (1968) Fine structural study of the terminal effector plexus, neuromuscular and intermuscular relationships in the pulmonary artery. J Anat 103:49–63

    Google Scholar 

  • Wagner J, Brodde OE (1978) On the presence and distribution of α-adrenoceptors in the heart of various mammalian species. Naunyn-Schmiedeberg's Arch Pharmacol 302:239–254

    Google Scholar 

  • Wagner J, Schümann HJ (1979) Stimulation of β-adrenoceptor by dobutamine in the guinea pig atria and tracheal chain. Naunyn-Schmiedeberg's Arch Pharmacol 308:19–23

    Google Scholar 

  • Wagner J, Schümann HJ, Knorr A, Rohm N, Chr Reidemeister J (1980) Stimulation of adrenaline and dopamine but not by noradrenaline of myocardial α-adrenoceptors mediating positive inotropic effects in human atrial preparations. Naunyn-Schmiedeberg's Arch Pharmacol 312:99–102

    Google Scholar 

  • Walkenhorst R, Reinhardt D, Arnold G (1981) Differentiation of cardiac and peripheral α- and β-responses to dobutamine, etilefrin and xylometazoline in dogs. Pharmacology 22:294–304

    Google Scholar 

  • Wikberg JES (1978) Pharmacological classification of adrenergic α-receptors in the guinea pig. Nature 273:164–166

    Google Scholar 

  • Woolf CM (1968) Principles of biometry; statistics for biologists. Van Nostrand, Princeton, New Jersey

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Cardiovascular Pharmacology (MC-304), Lilly Research Laboratories, Eli Lilly and Company, 46285, Indianapolis, Indiana, USA

    Robert R. Ruffolo Jr., Karen Messick & J. S. Horng

Authors
  1. Robert R. Ruffolo Jr.
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Karen Messick
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. J. S. Horng
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Ruffolo, R.R., Messick, K. & Horng, J.S. Interactions of three inotropic agents, ASL-7022, dobutamine and dopamine, with α- and β-adrenoceptors in vitro. Naunyn-Schmiedeberg's Arch. Pharmacol. 326, 317–326 (1984). https://doi.org/10.1007/BF00501436

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00501436

Key words

Search

Navigation